Channel:  SeroNet

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

57 Articles

Mathematical modeling to inform vaccination strategies and testing approaches for COVID-19 in nursing homes
Kahn, R., Holmdahl, I., Reddy, S., Jernigan, J., Mina, M. J., Slayton, R. B.
10.1101/2021.02.26.21252483 — Posted: 2021-03-01
Negligible impact of SARS-CoV-2 variants on CD4+ and CD8+ T cell reactivity in COVID-19 exposed donors and vaccinees.
Tarke, A., Sidney, J., Methot, N., Zhang, Y., Dan, J. M., Goodwin, B., Rubiro, P., Sutherland, A., da Silva Antunes, R., Fraizer, A., Rawlings, S. A., Smith, D. M., Peters, B., Scheuermann, R. H., Weiskopf, D., Crotty, S., Grifoni, A., Sette, A.
10.1101/2021.02.27.433180 — Posted: 2021-03-01
Prior COVID-19 Infection and Antibody Response to Single Versus Double Dose mRNA SARS-CoV-2 Vaccination
Ebinger, J. E., Fert-Bober, J., Printsev, I., Wu, M., Sun, N., Figueiredo, J. C., Van Eyk, J., Braun, J., Cheng, S., Sobhani, K.
10.1101/2021.02.23.21252230 — Posted: 2021-02-26
Integrated plasma proteomic and single-cell immune signaling network signatures demarcate mild, moderate, and severe COVID-19
Feyaerts, D., Hedou, J., Gillard, J., Chen, H., Tsai, E. S., Peterson, L. S., Ando, K., Manohar, M., Do, E., Dhondalay, G. K. R., Fitzpatrick, J., Artandi, M., Chang, I., Snow, T. T., Chinthrajah, R. S., Warren, C. M., Wittman, R., Meyerowitz, J. G., Ganio, E. A., Stelzer, I. A., Han, X., Verdonk, F., Gaudilliere, D. K., Mukherjee, N., Tsai, A. S., Rumer, K. K., Jiang, S. J., Valdes-Ferrer, S. I., Kelly, J. D., Furman, D., Aghaeepour, N., Angst, M. S., Boyd, S. D., Pinsky, B. A., Nolan, G. P., Nadeau, K. C., Gaudilliere, B., McIlwain, D. R.
10.1101/2021.02.09.430269 — Posted: 2021-02-12
Longitudinal Metabolomics of Human Plasma Reveals Robust Prognostic Markers of COVID-19 Disease Severity
Sindelar, M., Stancliffe, E., Schwaiger-Haber, M., Anbukumar, D. S., Albrecht, R. A., Liu, w.-c., Adkins-Travis, K., Garcia-Sastre, A., Shriver, L. P., Patti, G. J.
10.1101/2021.02.05.21251173 — Posted: 2021-02-08
Collaboration between the Fab and Fc contribute to maximal protection against SARS-CoV-2 in nonhuman primates following NVX-CoV2373 subunit vaccine with Matrix-M™ vaccination
Gorman, M. J., Patel, N., Guebre-Xabier, M., Zhu, A., Atyeo, C., Pullen, K., Loos, C., Goez-Gazi, Y., Carrion, R., Tian, J.-H., Yuan, D., Bowman, K., Zhou, B., Maciejewski, S., McGrath, M., Logue, J., Frieman, M., Montefiori, D., Mann, C., Schendel, S., Amanat, F., Krammer, F., Saphire, E. O., Lauffenburger, D. A., Greene, A. M., Portnoff, A. D., Massare, M. J., Ellingsworth, L., Glenn, G., Smith, G., Alter, G.
10.1101/2021.02.05.429759 — Posted: 2021-02-05
Host-directed therapies against early-lineage SARS-CoV-2 retain efficacy against B.1.1.7 variant
Reuschl, A.-K., Thorne, L., Zuliani Alvarez, L., Bouhaddou, M., Obernier, K., Hiatt, J., Soucheray, M., Turner, J., Fabius, J., Nguyen, G. T., Swaney, D., Rosales, R., White, K. M., Aviles, P., Kirby, I. T., Melnyk, J. E., Shi, Y., Zhang, Z., Shokat, K., Garcia-Sastre, A., Jolly, C., Towers, G. J., Krogan, N. J.
10.1101/2021.01.24.427991 — Posted: 2021-02-04
Sex disparities and neutralizing antibody durability to SARS-CoV-2 infection in convalescent individuals
Markmann, A. J., Gaillourou, N., Bhowmik, D. R., Hou, Y. J., Lermer, A., Martinez, D. R., Premkumar, L., Root, H., van Duin, D., Napravnik, S., Graham, S. D., Guerra, Q., Raut, R., Petropoulos, C. J., Wrin, T., Cornaby, C., Schmitz, J., Kuruc, J., Weiss, S., Park, Y., Baric, R., de Silva, A. M., Margolis, D. M., Bartelt, L. A.
10.1101/2021.02.01.21250493 — Posted: 2021-02-03
The E484K mutation in the SARS-CoV-2 spike protein reduces but does not abolish neutralizing activity of human convalescent and post-vaccination sera.
Jangra, S., Ye, C., Rathnasinghe, R., Stadlbauer, D., Personalized Virology Initiative (PVI) Study Group, , Krammer, F., Simon, V., Martinez-Sobrido, L., Garcia-Sastre, A., Schotsaert, M.
10.1101/2021.01.26.21250543 — Posted: 2021-01-29
The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera
Rathnasinghe, R., Jangra, S., Cupic, A., Martinez-Romero, C., Mulder, L. C. F., Kehrer, T., Yildiz, S., Choi, A., Mena, I., De Vrieze, J., Aslam, S., Stadlbauer, D., Meekins, D. A., McDowell, C. D., Balaraman, V., Richt, J. A., De Geest, B. G., Miorin, L., Personalized Virology Initiative, , Krammer, F., Simon, V., Garcia-Sastre, A., Schotsaert, M.
10.1101/2021.01.19.21249592 — Posted: 2021-01-20

RSS  Channel RSS